Key result
Modified Shenqi Dihuang and Zhenwu Decoction reduced serum creatinine from 520 to 471 μmol/L and relieved orthopnea and edema in a patient with Type 4 cardiorenal syndrome.
Why the study?
This study explores the correlation between the Huangdi Neijing theory that Yang governs qi transformation while Yin constitutes tangible structures and the onset and development of cardiorenal syndrome.
Case Report (n=1)
No
This paper outlines Professor Zhang Peiqing's Traditional Chinese Medicine clinical experience and stage-specific treatment framework for cardiorenal syndrome based on the 'Yang Transforming Qi, Yin Forming Form' theory, illustrated by a clinical case showing improved symptoms and reduced serum creatinine.
Answers are grounded in this paper and cite their sources.
Should not change cardiorenal syndrome practice; hypothesis-generating for TCM strategies pending controlled trials.
Drawing on the Huangdi Neijing's theory that Yang governs qi transformation while Yin constitutes tangible structures, this study explores its correlation with the onset and development of cardiorenal syndrome (CRS).Professor Zhang Peiqing believes that the core pathogenesis of CRS is the deficiency of Yang qi in the heart and kidney, impaired transformation functions, and stagnation of Yin pathogens such as phlegm, blood stasis, dampness, and toxins-characterizing a condition of underlying deficiency with superficial excess.Treatment should be stage-specific, addressing both temporary and permanent solutions: warming Yang qi and transforming the qi to consolidate the foundation, while promoting blood circulation and eliminating dampness to expel Yin pathogens.Attention must also be paid to seeking Yang within Yin and Yin within Yang.This approach often yields favorable clinical outcomes.
No takes yet. Share an insight, caveat, or question.
妞妞 刘 (2026) conducted a case report in Cardiorenal syndrome (Type 4) with stage 5 chronic kidney disease and congestive heart failure (n=1). Modified Shenqi Dihuang Decoction combined with Zhenwu Decoction was evaluated on Serum creatinine and clinical symptoms of heart failure. Modified Shenqi Dihuang and Zhenwu Decoction reduced serum creatinine from 520 to 471 μmol/L and relieved orthopnea and edema in a patient with Type 4 cardiorenal syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: